Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease
Journal of Atherosclerosis and Thrombosis · 01.11.2023 · 30 (11) · 1635-1643
DOI: 10.5551/jat.64047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.11.2023. Verfasst von Kotaro Tokuda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nagoya University graduate school of medicine. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
AIM: Chronic inflammation is associated with atherosclerosis development. Chronic kidney disease (CKD) is an independent risk factor for cardiovascular events and is associated with chronic inflammation. We aimed to investigate the influence of C-reactive protein (CRP), an important marker of inflammation, on the clinical outcomes of patients with CKD and stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). METHODS: Among patients with stable CAD and CKD who underwent PCI, 516 patients whose CRP levels were available before the PCI procedure were identified. The patients were divided into two groups according to the CRP levels: those with CRP ≥ 2.0 mg/L (high-CRP group) and those with CRP <2.0 mg/L (low-CRP group). The primary endpoint of this study was the occurrence of major adverse cardiac events (MACE), defined as a composite of cardiac death, myocardial infarction, and unplanned revascularization. RESULTS: Overall, the mean age of the patients was 72.5±9.7 years, and 20.7% were female. The median CRP level was 1.43 mg/L (0.6-4.9 mg/L). The median follow-up period was 3.6 years. The occurrence of MACE was significantly higher in the high-CRP group than in the low-CRP group (log-rank p<0.001). Notably, the incidence rate of cardiac death was significantly higher in the high-CRP group (log-rank p<0.001). According to the multivariable analysis, CRP level ≥ 2.0 mg/L was found to be a significant predictor of MACE (hazard ratio [HR]: 1.54, 95% confidence interval [CI]: 1.04-2.28, p=0.003), as well as estimated glomerular filtration rate (HR: 0.98, 95% CI: 0.97-0.99, p<0.01). CONCLUSION: High-CRP levels adversely affect long-term cardiac events in patients with stable CAD and CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Nagoya University graduate school of medicine.
- Department of Cardiology, Gunma University Graduate School of Medicine.
Zitieren
APA
Tokuda, K., Tanaka, A., Tobe, A., Shirai, Y., Kurobe, M., Kubota, Y., Kunieda, T., Miyazaki, T., Mizutani, K., Furusawa, K., Ishii, H., & Murohara, T. (2023). Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease. Journal of Atherosclerosis and Thrombosis, 30(11), 1635-1643. https://doi.org/10.5551/jat.64047
Vancouver
Tokuda K, Tanaka A, Tobe A, Shirai Y, Kurobe M, Kubota Y, et al. Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease. Journal of Atherosclerosis and Thrombosis. 2023;30(11):1635-1643. doi:10.5551/jat.64047
BibTeX
@article{Tokuda2023,
author = {Tokuda, Kotaro and Tanaka, Akihito and Tobe, Akihiro and Shirai, Yoshinori and Kurobe, Masanari and Kubota, Yoshiaki and Kunieda, Takeshige and Miyazaki, Tatsuya and Mizutani, Koji and Furusawa, Kenji and Ishii, Hideki and Murohara, Toyoaki},
title = {Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2023},
volume = {30},
number = {11},
pages = {1635--1643},
doi = {10.5551/jat.64047}
}
EUVIMED